Back
Supernus Pharmaceuticals Stock Price Chart
Better Than Oil Stocks
CLICK HERE TO FIND OUT MORE
Sell
28
SUPN
Supernus Pharmaceuticals
Last Price:
36.12
Seasonality Move:
6.46%
7 Day Trial
ALL ACCESS PASS
$
7
Zero Day Options Trade LIVE Tuesday at 2 p.m. ET!
Discover The Zero Day Loophole (BEFORE Tues at 2 p.m. ET!)- The current trend is moderately bearish and SUPN is experiencing selling pressure, which indicates risk of future bearish movement.
Supernus Pharmaceuticals Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 36.85 | Sell |
| 20-day SMA: | 36.43 | Sell |
| 50-day SMA: | 35.09 | Buy |
| 200-day SMA: | 31.65 | Buy |
| 8-day EMA: | 36.68 | Sell |
| 20-day EMA: | 36.44 | Sell |
| 50-day EMA: | 35.31 | Buy |
| 200-day EMA: | 32.33 | Buy |
Supernus Pharmaceuticals Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.43 | Buy |
| Relative Strength Index (14 RSI): | 49.72 | Sell |
| Chaikin Money Flow: | -284593 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (35.9 - 37.2) | Sell |
| Bollinger Bands (100): | (31.28 - 36.04) | Buy |
Supernus Pharmaceuticals Technical Analysis
| Nov 29 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 6 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | Dec | |||||||||
| 29 | 02 | 03 | 04 | 05 | 06 | 09 | 10 | 11 | 12 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Supernus Pharmaceuticals Stock
Is Supernus Pharmaceuticals Stock a Buy?
- Supernus Pharmaceuticals share price is 36.16 while SUPN 8-day simple moving average is 36.85, which is a Sell signal.
- The stock price of SUPN is 36.16 while Supernus Pharmaceuticals 20-day SMA is 36.43, which makes it a Sell.
- Supernus Pharmaceuticals 50-day simple moving average is 35.09 while SUPN share price is 36.16, making it a Buy technically.
- SUPN stock price is 36.16 and Supernus Pharmaceuticals 200-day simple moving average is 31.65, creating a Buy signal.
SUPN Technical Analysis vs Fundamental Analysis
Sell
28
Supernus Pharmaceuticals (SUPN)
is a Sell
Is Supernus Pharmaceuticals a Buy or a Sell?
-
Supernus Pharmaceuticals stock is rated a Sell
The current Supernus Pharmaceuticals [SUPN] share price is $36.16. The Score for SUPN is 28, which is 44% below its historic median score of 50, and infers higher risk than normal.
Supernus Pharmaceuticals Stock Info
Market Cap:
2B
Price in USD:
36.16
Share Volume:
322.04K
Supernus Pharmaceuticals 52-Week Range
52-Week High:
39.37
52-Week Low:
25.53
Sell
28
Supernus Pharmaceuticals (SUPN)
is a Sell
Supernus Pharmaceuticals Share Price Forecast
-
What is the Supernus Pharmaceuticals stock price today?
The Supernus Pharmaceuticals stock price is 36.16 USD today. -
Will SUPN stock go up or go down?
Supernus Pharmaceuticals> share price is forecast to RISE/FALL based on technical indicators -
Is Supernus Pharmaceuticals overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Supernus Pharmaceuticals is overvalued.
Is Supernus Pharmaceuticals Stock a Buy?
- Supernus Pharmaceuticals share price is 36.16 while SUPN 8-day exponential moving average is 36.68, which is a Sell signal.
- The stock price of SUPN is 36.16 while Supernus Pharmaceuticals 20-day EMA is 36.44, which makes it a Sell.
- Supernus Pharmaceuticals 50-day exponential moving average is 35.31 while SUPN share price is 36.16, making it a Buy technically.
- SUPN stock price is 36.16 and Supernus Pharmaceuticals 200-day simple moving average is 32.33, creating a Buy signal.
Fundamental Analysis of Supernus Pharmaceuticals
Is Supernus Pharmaceuticals a good investment?
- Analysts estimate an earnings increase this quarter of $0.07 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.87 per share, and a decrease next year of $0.96 per share.
Technical Analysis of Supernus Pharmaceuticals
Should I short Supernus Pharmaceuticals stock?
- SUPN Moving Average Covergence Divergence (MACD) indicator is 0.43, suggesting Supernus Pharmaceuticals is a Buy
- Supernus Pharmaceuticals Relative Strength Index (RSI) is 49.72, which suggest Supernus Pharmaceuticals is oversold
- The Bollinger Bands (25) for Supernus Pharmaceuticals is (35.9 - 37.2), which suggest Supernus Pharmaceuticals is a Buy
- The Bollinger Bands (100) for Supernus Pharmaceuticals is (31.28 - 36.04), which suggest Supernus Pharmaceuticals is a Buy
* Supernus Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.